Laboratory Corp of America Holdings logo

Laboratory Corp of America Holdings LH

Market Closed
12 Nov, 20:00
NYSE NYSE
$
244. 26
+0.34
+0.14%
After Hours
$
244. 26
0 0%
22.53B Market Cap
- P/E Ratio
2.88% Div Yield
737,679 Volume
- Eps
$ 243.92
Previous Close
Day Range
242.99 246.96
Year Range
191.97 247.99

LH Chart

Laboratory Corp of America Holdings Profile

Diagnostics & Research Industry
Healthcare Sector
Mr. Adam H. Schechter CEO
NYSE Exchange
US50540R4092 ISIN
United States Country
67,000 Employees
26 Nov 2024 Last Dividend
20 May 2024 Last Split
29 Mar 1990 IPO Date

Overview

Laboratory Corporation of America Holdings, widely known as Labcorp, is a pioneering life sciences company that plays a crucial role in the healthcare industry by providing essential information aiding in clear and confident decision-making for doctors, hospitals, pharmaceutical companies, researchers, and patients. With a deep commitment to improving health and improving lives, Labcorp operates through two primary segments: Labcorp Diagnostics, which focuses on a wide array of testing services, and Labcorp Drug Development, dedicated to supporting the pharmaceutical and biotech industries in bringing new drugs and therapies to market. The company's history dates back to 1994, and it has since established its headquarters in Burlington, North Carolina, positioning itself as a leader in medical diagnostics and drug development services. Through its extensive range of services and a global network, Labcorp facilitates better health outcomes for millions of people worldwide.

Products and Services

Labcorp distinguishes itself by offering an extensive portfolio of services that cater to various stakeholders in the healthcare and biomedical sectors. Below are some of the key products and services provided by the company:

  • Diagnostic Tests - Labcorp conducts a wide range of routine and specialized diagnostic tests, including but not limited to, blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, vitamin D levels, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, and alcohol and substance-abuse tests. These tests are crucial for early detection, monitoring, and treatment of diseases.
  • Specialty Testing Services - The company provides gene-based and esoteric testing services targeting specific diseases and conditions. This includes anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing, offering advanced diagnostic solutions for complex health questions.
  • Occupational Testing Services - Labcorp extends its services to employers and managed care organizations (MCOs), delivering occupational testing services, medical drug monitoring, chronic disease programs, and kidney stone prevention tests. These services are designed to enhance workplace safety, compliance with regulations, and overall employee health.
  • Health and Wellness Services - The company offers health and wellness services, including health fairs, on-site and at-home testing, vaccinations, and health screenings. These services aim to promote preventative care and healthier lifestyles among employees and communities.
  • Online and Mobile Applications - To facilitate easier access to test results and services, Labcorp offers online and mobile applications that enable patients to view their test results conveniently. It also provides online applications for MCOs and accountable care organizations to manage and streamline healthcare services effectively.
  • Drug Development - Labcorp Drug Development unit offers comprehensive end-to-end drug development, medical device, and companion diagnostic development solutions. From early-stage research to clinical development and commercial market access, Labcorp supports a range of requirements for pharmaceutical, biotechnology, medical device, and diagnostics companies.

Contact Information

Address: 358 South Main Street
Phone: 336 229 1127